Literature DB >> 34839177

Partial STAT5 signaling is sufficient for CD4+ T cell priming but not memory formation.

Michelle Fleury1, Cristina Vazquez-Mateo2, Jaileene Hernandez-Escalante1, Hans Dooms3.   

Abstract

Signal transducer and activator of transcription 5 (STAT5) plays an important role in regulating gene expression in response to cytokines of the common (γc) chain family. In this capacity, STAT5 promotes CD8+ effector and memory T cell survival and regulatory T cell development. However, its function in conventional CD4+ T cells is less clear. In this study, the requirement of intact STAT5 signaling for CD4+ effector and memory T cell generation and maintenance was investigated by using DO11.10 TCR transgenic T cells that are genetically deficient in STAT5A or B, as well as by transducing DO11 T cells with a dominant-negative STAT5 to temporally block STAT5 function. We found that the presence of STAT5A or B alone was sufficient for primary CD4+ effector T cell generation, but not for establishing a long-lived memory cell population. Similarly, blocking STAT5 signaling during priming did not prevent initial T cell activation, but inhibited the generation of memory cells. Surprisingly, blocking STAT5 post-priming did not impact the long-term survival of CD4+ memory T cells in vivo. Mechanistically, intact STAT5B, but not STAT5A, was required for IL-7Rα re-expression in activated T cells, which is an important cytokine receptor for CD4+ memory generation. These data show that fully functional STAT5 is essential to deliver an early, non-redundant signal for memory programming during the primary CD4+ T cell response, while partial STAT5 signaling is sufficient for effector differentiation. Our results have implications for the precise use of STAT5 inhibitors to timely inhibit memory T cell responses.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34839177      PMCID: PMC8761165          DOI: 10.1016/j.cyto.2021.155770

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  43 in total

1.  Molecular and functional profiling of memory CD8 T cell differentiation.

Authors:  Susan M Kaech; Scott Hemby; Ellen Kersh; Rafi Ahmed
Journal:  Cell       Date:  2002-12-13       Impact factor: 41.582

Review 2.  Programming, demarcating, and manipulating CD8+ T-cell memory.

Authors:  Vladimir P Badovinac; John T Harty
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

Review 3.  Effector and memory CTL differentiation.

Authors:  Matthew A Williams; Michael J Bevan
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

4.  STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression.

Authors:  Ferenc A Scheeren; Marianne Naspetti; Sean Diehl; Remko Schotte; Maho Nagasawa; Erwin Wijnands; Ramon Gimeno; Florry A Vyth-Dreese; Bianca Blom; Hergen Spits
Journal:  Nat Immunol       Date:  2005-02-13       Impact factor: 25.606

5.  IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.

Authors:  Matthew A Burchill; Jianying Yang; Christine Vogtenhuber; Bruce R Blazar; Michael A Farrar
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

6.  The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.

Authors:  Rajesh R Rao; Qingsheng Li; Kunle Odunsi; Protul A Shrikant
Journal:  Immunity       Date:  2010-01-07       Impact factor: 31.745

7.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

Authors:  Matthew A Williams; Aaron J Tyznik; Michael J Bevan
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

8.  Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis.

Authors:  Yuko Kato; Atsushi Iwama; Yuko Tadokoro; Kazuya Shimoda; Mayu Minoguchi; Shizuo Akira; Minoru Tanaka; Atsushi Miyajima; Toshio Kitamura; Hiromitsu Nakauchi
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

9.  IL-7 promotes the transition of CD4 effectors to persistent memory cells.

Authors:  JiChu Li; Gail Huston; Susan L Swain
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  IL-2/IL-7-inducible factors pioneer the path to T cell differentiation in advance of lineage-defining factors.

Authors:  Sarah L Bevington; Peter Keane; Jake K Soley; Saskia Tauch; Dominika W Gajdasik; Remi Fiancette; Veronika Matei-Rascu; Claire M Willis; David R Withers; Peter N Cockerill
Journal:  EMBO J       Date:  2020-09-15       Impact factor: 14.012

View more
  1 in total

Review 1.  Recent research on the association between signal transducer and activator of transcription 5 and childhood acute lymphoblastic leukemia.

Authors:  Yi-Fei Duan; Fei-Qiu Wen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.